Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C3H7Na2O6P · 5H2O
CAS Number:
Molecular Weight:
306.11
UNSPSC Code:
12352302
NACRES:
NA.77
MDL number:
Quality Level
description
Merck USA index - 14, 4486
assay
≥97% (titration)
form
powder
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated
color
white
solubility
water: 5 mg/mL
anion traces
chloride (Cl-): ≤0.010%, phosphate (PO43-): ≤0.010%
cation traces
As: ≤0.00050%, heavy metals (as Pb): ≤0.0020%
shipped in
ambient
storage temp.
2-8°C
SMILES string
[Na+].[Na+].[P](=O)([O-])([O-])OC(CO)CO.O.O.O.O.O
InChI
1S/C3H9O6P.2Na.5H2O/c4-1-3(2-5)9-10(6,7)8;;;;;;;/h3-5H,1-2H2,(H2,6,7,8);;;5*1H2/q;2*+1;;;;;/p-2
InChI key
PEMUISUYOHQFQH-UHFFFAOYSA-L
General description
A phosphate group donor in matrix mineralization studies. Accelerates calcification in vascular smooth muscle cells. Also acts as a protein phosphatase inhibitor.
Biochem/physiol Actions
Cell permeable: no
Product does not compete with ATP.
Reversible: no
Other Notes
Fujimoto, H., and Mabuchi, I. 1997. J. Biochem. 122, 518.
Lecanda, F., et al. 1997. J. Cell Biochem. 67, 386.
Laurencin, C.T., et al. 1996. Bone 19, 93s.
Shioi, A., et al. 1995. Arterioscler. Thromb. Vasc. Biol. 15, 2003.
Lecanda, F., et al. 1997. J. Cell Biochem. 67, 386.
Laurencin, C.T., et al. 1996. Bone 19, 93s.
Shioi, A., et al. 1995. Arterioscler. Thromb. Vasc. Biol. 15, 2003.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Antonella Stanzione et al.
Biomaterials science, 9(22), 7492-7503 (2021-10-14)
Motor neuron diseases are neurodegenerative diseases that predominantly affect the neuromuscular system. To date, there are no valid therapeutic treatments for such diseases, and the classical experimental models fail in faithfully reproducing the pathological mechanisms behind them. In this regard
G Ruiz-Heiland et al.
Clinical oral investigations, 25(4), 1933-1944 (2020-08-21)
Juvenile obesity is a complex clinical condition that is present more and more frequently in the daily orthodontic practice. Over-weighted patients have an impaired bone metabolism, due in part to their increased levels of circulating adipokines. Particularly, leptin has been
Justyna M Kowal et al.
Stem cells translational medicine, 9(2), 189-202 (2019-11-24)
Cultured human bone marrow stromal (mesenchymal) stem cells (hBM-MSCs) are heterogenous cell populations exhibiting variable biological properties. Quantitative high-content imaging technology allows identification of morphological markers at a single cell resolution that are determinant for cellular functions. We determined the